Fady Ibraham Malik - 09 Feb 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role: EVP Research & Development
Signature: /s/ John Faurescu, attorney-in-fact for Dr. Malik
Issuer symbol: CYTK
Transactions as of: 09 Feb 2023
Net transactions value: -$250,460
Form type: 4
Filing time: 09 Feb 2023, 15:22:01 UTC
Previous filing: 12 Jan 2023
Next filing: 10 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTK	Common Stock	Options Exercise	$55,720	+7,000	+4.5%	$7.96^*	163,589	09 Feb 2023	Direct	F1
transaction	CYTK	Common Stock	Sale	$306,180	-7,000	-4.3%	$43.74	156,589	09 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTK	Non-Qualified Stock Option (Right to Buy)	Options Exercise	$0	-7,000	-7.9%	$0.000000	81,322	09 Feb 2023	Common Stock	7,000	$7.96	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 20, 2022.